SARAH NALLY: Open Payments
NPI 1295456317 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 20 payments from 9 companies in 2025. Trend: 2023 $223 · 2024 $404 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $96 |
| ABBVIE INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Medtronic, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Ozempic, VRAYLAR, TRELEGY ELLIPTA, JARDIANCE, BREZTRI, INCEPTIV, FARXIGA, PAXLOVID.
Industry payments across WV — which companies pay providers there.
